Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230397 | SCV000290529 | uncertain significance | Multiple endocrine neoplasia, type 2 | 2023-05-31 | criteria provided, single submitter | clinical testing | An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 241335). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is present in population databases (rs529018971, gnomAD 0.01%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 47 of the RET protein (p.Gly47Ser). |
Counsyl | RCV000662387 | SCV000784791 | uncertain significance | Multiple endocrine neoplasia type 2A | 2016-12-13 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820759 | SCV002069955 | uncertain significance | not specified | 2019-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392716 | SCV002701735 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |